Losartan, a nonpeptide angiotensin II (Ang II) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteries-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Losartan, a nonpeptide angiotensin II (Ang II) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteries

Published:1991-01 Issue:25 Volume:49 Page:PL223-PL228
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Kauffman Raymond F.,Bean James S.,Zimmerman Karen M.,Brown Raymond F.,Steinberg Mitchell I.

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference22 articles.

1. The Pathogenesis of Atherosclerosis — An Update

2. Replication of smooth muscle cells in vascular disease.

3. Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia.

4. PDGF ligand and receptor gene expression during repair of arterial injury.

5. Role of basic fibroblast growth factor in vascular lesion formation.

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renin and (pro)renin receptors induce vascular smooth muscle cell proliferation and neointimal hyperplasia by activating oxidative stress and inflammation;Vascular Medicine;2024-08-30

2. The quest for effective pharmacological suppression of neointimal hyperplasia;Current Problems in Surgery;2020-08

3. Thyroid Hormone and Vascular Remodeling in Heart;Thyroid and Heart;2020

4. The combination of valsartan and ramipril protects against blood vessel injury and lowers blood pressure;Journal of Pharmaceutical Investigation;2016-03-23

5. Angiotensinergic neurotransmission in the paraventricular nucleus of the hypothalamus modulates the pressor response to acute restraint stress in rats;Neuroscience;2014-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3